Guerbet Celebrates 90 Years, Inaugural Year in St. Louis

Share Article

France-based global imaging leader will plant 90 trees in Franz Park and Francis Slay Park for 90th anniversary.

On November 12, 2016 more than 20 employees of the Guerbet Group, a France-based global specialist in contrast agents and solutions for medical imaging, will gather to plant 90 trees in Franz Park and Francis Slay Park in celebration of the company’s 90th anniversary—and its first year spent in St. Louis. In 2015, Guerbet opened the America’s Shared Service Center in St Louis. The planting of the trees is symbolic of the Group’s roots and growth, from the early days of medical imaging to its most recent applications, and its plans for a bright future in St. Louis.

The St. Louis office started in 2015, under the entity named Liebel-Flarsheim, with 70 employees transferred from the contrast media and delivery system business acquired from Mallinckrodt. It is now the company’s most important Shared Service Center in the Guerbet organization with 130 employees. Employees at the St. Louis office work in Finance, IT, and Supply Chain/Customer Service for North and South America, in addition to managing some of the company’s operations worldwide.

“The tree planting ceremony is an opportunity to thank our staff and share with our partners the values that contribute to Guerbet’s success,” said Bruno Bonnemain, St Louis Site Director. “These ideals include innovation, respect for all the stakeholders in our ecosystem and the long-term development vision, and the integration of employees with different cultures and ways of working.”

Guerbet is an international group, currently employing 2,600 people worldwide. Although 1,000 of the company’s employees are based in France, eighty-five percent of the company’s sales are achieved outside of France. The company’s growth drivers include being contrast agents for MRIs, contrast agents for X-ray imaging, Interventional Radiology, and Theranostics, and Imaging Solutions and Services, including medical devices such as injectors.

The Group doubled in size in 2015 following the acquisition of Mallinckrodt’s “Contrast Media and Delivery Systems” business. Plans to expand the St. Louis office are underway.

“I would like to thank the staff of the St. Louis site for their strong contribution to the success of Guerbet, which is experiencing a key period in its history,” said Yves L’Epine, Guerbet CEO. “We are in the process of successfully integrating our major acquisition to build a new global leader in medical imaging. More than ever, offering indispensable solutions for diagnostic and interventional imaging all over the world is paramount. Faced with the challenges of aging, the development of chronic diseases, and certain cancers that remain difficult to treat, medical imaging opens up an exceptional range of predictive capabilities to benefit patients.”


About Guerbet
Guerbet is a pioneer in the contrast agent field, with 90 years’ experience, and is the only pharmaceutical group dedicated to medical imaging worldwide. It offers a comprehensive range of X-Ray, Magnetic Resonance Imaging (MRI) and Interventional Radiology and Theranostics (IRT) products, along with a range of injectors and related medical devices to improve the diagnosis and treatment of patients. To discover new products and ensure future growth, Guerbet invests heavily in R&D, spending around 9% of its sales each year. Guerbet (GBT) is listed on Euronext Paris (Segment B – Mid Caps) and generated €789 million in pro forma revenue in 2015. For more information about Guerbet, please visit

Media contacts:

Liebel Flarsheim, a Guerbet Group company /L (St. Louis)
Bruno Bonnemain, St Louis Site Director
+1 (314)376 4708

Anne-Laure Delasalle, Communications Director
+33 (0)1 45 91 50 03

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Andrea Arco
Follow us on
Visit website